SGMO: Sangamo Therapeutics, Inc. Common Stock Company Profile & Statistics

About

Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc., formerly known as Sangamo BioSciences Inc., is based in Richmond, United States.

Info & Links

CEO

Alexander D. Macrae

Headquarters

501 Canal Blvd
Richmond, CA 94804, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

183

Sangamo Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

121.23M

Enterprise Value

96.05M

Enterprise Value/EBITDA(ttm)

-1.31

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

4.47

Price to Book(mrq)

5.97

Price to Cash(ytd)

30.42

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-255.62%

Profit Margin(ttm)

-2727.97%

Return on Equity(ttm)

-264.16%

Return on Invested Capital(ttm)

-851.65%

Return on Assets(ttm)

-107.24%

Income Statement

Revenue(ttm)

63.76M

Revenue Per Share(ttm)

0.27

Gross Profit(ttm)

63.76M

EBITDA(ttm)³

-73.31M

Net Income Available to Common(ttm)

-79.45M

Diluted EPS(ttm)

-0.75

Share Statistics

Beta (5Y Monthly)

1.30

52-Week Change

-3.42%

S&P 500 52-Week Change

9.20%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

233.17M

Dividend Yield

0.00%

Float⁴

202.81M

% Held by Insiders

2.80%

% Held by Institutions

56.93%

Balance Sheet

Total Cash(mrq)

25.18M

Total Cash Per Share(mrq)

0.11

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.76%

Quick Ratio(mrq)

1.35%

Book Value Per Share(mrq)

0.02

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.12

Free Cash Flow(ytd)

-26.15M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

SGMO

Sangamo Therapeutics, Inc. Common Stock

Sangamo Therapeutics, Inc. Common Stock Profile